Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lintuzumab myeloid cell surface antigen cd33 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 discontinued in phase 2 antibody
lintuzumab myeloid cell surface antigen cd33 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 discontinued in phase 2 unknown
click here to return to the previous page